Lee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, Rebecca Clark-Snow, Rita Wickham, Dwight Kloth, Gary Binder, William L Bailey, Marco Turini, Ravi Potluri, Xing Liu, Eros Papademetriou, Eric J Roeland
PURPOSE: Chemotherapy-induced nausea and vomiting (CINV)'s impact on work loss remains poorly described. We evaluated associations between the duration of CINV episodes, CINV-related work loss (CINV-WL), and CINV-related activity impairment (CINV-AI) in patients with breast cancer receiving highly emetogenic chemotherapy. METHODS: We analyzed data from a prospective CINV prophylaxis trial of netupitant/palonestron and dexamethasone for patients receiving an anthracycline and cyclophosphamide (AC) for breast cancer (NCT0340371)...
October 25, 2023: Supportive Care in Cancer